Why biological data matters more in AI drug discovery
GSK has entered into a research collaboration with British biotechnology company Relation Therapeutics worth up to $110 million, expanding the companies’ existing work in AI-assisted drug discovery. Under the agreement, Relation will generate large-scale datasets measuring how human cells respond to
GSK has entered into a research collaboration with British biotechnology company Relation Therapeutics worth up to $110 million, expanding the companies’ existing work in AI-assisted drug discovery. Under the agreement, Relation will generate large-scale datasets measuring how human cells respond to genetic changes and drug interventions. The data will be used to train AI models […] The post Why biological data matters more in AI drug discovery appeared first on AI News.
Key Takeaways
- •GSK has entered into a research collaboration with British biotechnology company Relation Therapeutics worth up to $110 million, expanding the companies’ existing work in AI-assisted drug discovery
- •This story was reported by AI News Daily, covering developments in the news space.
- •AI advancements continue to reshape industries — read the full article on AI News Daily for complete coverage.
📖 Continue reading the full article:
Read Full Article on AI News Daily →
